Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Aug-12 7:03 PM View:  | Pure Bioscience (PURE) | 31-Jul-12 | Grant | 13,710 | $0.38 | $5,209.80 | 2% 704.59K to 718.3K | (72%) |
| 27-Mar-12 2:25 PM View: | Osiris Therapeutics, Inc. (OSIR) | 23-Mar-12 | Grant | 5,000 | $5.08 | $25,400.00 | 6% 77.42K to 82.42K | 280% |
| 01-Jul-11 4:10 PM View: | Pure Bioscience (PURE) | 29-Jun-11 | Market Purchase | 50,000 | $0.78 | $38,765.00 | 8% 654.59K to 704.59K | (86%) |
| 22-Jun-11 6:04 PM View: | Pure Bioscience (PURE) | 21-Jun-11 | Market Purchase | 25,000 | $0.89 | $22,345.00 | 4% 629.59K to 654.59K | (88%) |
| 06-Jun-11 4:04 PM View: | Osiris Therapeutics, Inc. (OSIR) | 06-Jun-11 | Market Purchase | 25,000 | $7.07 | $176,695.00 | 48% 52.42K to 77.42K | 174% |
| 06-Jun-11 4:04 PM View: | Osiris Therapeutics, Inc. (OSIR) | 03-Jun-11 | Market Purchase | 25,000 | $7.20 | $179,965.00 | 91% 27.42K to 52.42K | 169% |
| 11-Mar-11 4:21 PM View: | Pure Bioscience (PURE) | 09-Mar-11 | Option Exercise | 50,000 | $1.65 | $82,500.00 | 9% 579.59K to 629.59K | |
| 16-Feb-11 6:40 AM View: | Osiris Therapeutics, Inc. (OSIR) | 14-Feb-11 | Grant | 5,000 | $7.13 | $35,650.00 | 22% 22.42K to 27.42K | 171% |
| 25-Jan-11 5:10 PM View: | Pure Bioscience (PURE) | 21-Jan-11 | Grant | 13,300 | $2.13 | $28,329.00 | 2% 566.29K to 579.59K | (95%) |
| 05-Jan-11 4:14 PM View: | Pure Bioscience (PURE) | 03-Jan-11 | Payment of Exercise | 11,778 | $2.25 | $26,500.50 | (2%) 578.07K to 566.29K | 95% |
| 05-Jan-11 4:14 PM View: | Pure Bioscience (PURE) | 03-Jan-11 | Option Exercise | 50,000 | $0.53 | $26,500.00 | 9% 528.07K to 578.07K | |
| 09-Dec-10 4:22 PM View: | Pure Bioscience (PURE) | 08-Dec-10 | Gift | 1,000 | $2.43 | $2,430.00 | (< 1%) 529.07K to 528.07K | 96% |
| 09-Dec-10 4:22 PM View: | Pure Bioscience (PURE) | 07-Dec-10 | Gift | 2,780 | $2.23 | $6,213.30 | (< 1%) 531.85K to 529.07K | 95% |
| 30-Nov-10 5:14 PM View: | Pure Bioscience (PURE) | 29-Nov-10 | Gift | 897 | $2.17 | $1,946.49 | (< 1%) 532.74K to 531.85K | 95% |
| 22-Nov-10 5:27 PM View: | Pure Bioscience (PURE) | 19-Nov-10 | Gift | 24,000 | $2.40 | $57,600.00 | (4%) 556.54K to 532.54K | 96% |
| 01-Nov-10 7:05 PM View: | Pure Bioscience (PURE) | 01-Nov-10 | Gift | 1,500 | $2.51 | $3,765.00 | (< 1%) 558.04K to 556.54K | 96% |
| 09-Jul-10 7:46 PM View: | Pure Bioscience (PURE) | 07-Jul-10 | Market Purchase | 5,000 | $1.84 | $9,199.50 | < 1% 553.04K to 558.04K | (94%) |
| 30-Jun-10 6:30 PM View: | Pure Bioscience (PURE) | 29-Jun-10 | Gift | 7,400 | $2.52 | $18,648.00 | (1%) 560.44K to 553.04K | 96% |
| 01-Jun-10 4:04 PM View: | Osiris Therapeutics, Inc. (OSIR) | 27-May-10 | Grant | 5,000 | $6.46 | $32,300.00 | 29% 17.42K to 22.42K | 205% |
| 10-May-10 8:40 AM View: | Pure Bioscience (PURE) | 06-May-10 | Grant | 20,400 | $3.03 | $61,812.00 | 4% 540.04K to 560.44K | (96%) |
| 16-Apr-10 4:16 PM View: | Pure Bioscience (PURE) | 14-Apr-10 | Market Purchase | 5,000 | $2.72 | $13,600.00 | < 1% 535.04K to 540.04K | (96%) |
| 07-Apr-10 9:42 PM View: | Pure Bioscience (PURE) | 06-Apr-10 | Market Purchase | 10,000 | $2.02 | $20,156.00 | 2% 525.04K to 535.04K | (95%) |
| 15-Mar-10 8:42 PM View: | Pure Bioscience (PURE) | 15-Mar-10 | Market Purchase | 10,000 | $1.80 | $18,000.00 | 2% 515.04K to 525.04K | (94%) |
| 28-Jan-10 6:58 PM View: | Pure Bioscience (PURE) | 27-Jan-10 | Market Sale | 28,492 | $1.35 | $38,521.20 | (5%) 543.54K to 515.04K | 92% |
| 28-Jan-10 6:58 PM View: | Pure Bioscience (PURE) | 26-Jan-10 | Market Sale | 40,000 | $1.36 | $54,544.00 | (7%) 555.04K to 515.04K | 92% |
| 21-Jan-10 4:57 PM View: | Pure Bioscience (PURE) | 21-Jan-10 | Private Sale | 27,090 | $1.55 | $41,873.00 | (4%) 610.63K to 583.54K | |
| 21-Jan-10 4:57 PM View: | Pure Bioscience (PURE) | 20-Jan-10 | Market Sale | 29,410 | $1.44 | $42,412.20 | (5%) 612.95K to 583.54K | 93% |
| 21-Jan-10 4:57 PM View: | Pure Bioscience (PURE) | 19-Jan-10 | Market Sale | 3,500 | $1.50 | $5,250.00 | (< 1%) 587.04K to 583.54K | 93% |
| 15-Jan-10 4:34 PM View: | Pure Bioscience (PURE) | 15-Jan-10 | Market Sale | 700 | $1.55 | $1,081.99 | (< 1%) 637.24K to 636.54K | 93% |
| 15-Jan-10 4:34 PM View: | Pure Bioscience (PURE) | 14-Jan-10 | Market Sale | 1,110 | $1.57 | $1,742.81 | (< 1%) 637.65K to 636.54K | 93% |
| 15-Jan-10 4:34 PM View: | Pure Bioscience (PURE) | 13-Jan-10 | Market Sale | 11,700 | $1.61 | $18,827.60 | (2%) 648.24K to 636.54K | 93% |
| 31-Dec-09 4:36 PM View: | Pure Bioscience (PURE) | 30-Dec-09 | Gift | 17,865 | $1.46 | $26,082.90 | (3%) 667.91K to 650.05K | 93% |
| 31-Dec-09 4:36 PM View: | Pure Bioscience (PURE) | 29-Dec-09 | Gift | 15,000 | $1.43 | $21,450.00 | (2%) 665.05K to 650.05K | 93% |
| 29-Dec-09 5:05 PM View: | Pure Bioscience (PURE) | 24-Dec-09 | Market Sale | 1,000 | $1.39 | $1,390.00 | (< 1%) 699.25K to 698.25K | 92% |
| 23-Dec-09 5:29 PM View: | Pure Bioscience (PURE) | 23-Dec-09 | Market Sale | 1,500 | $1.43 | $2,145.00 | (< 1%) 700.75K to 699.25K | 93% |
| 23-Dec-09 5:29 PM View: | Pure Bioscience (PURE) | 22-Dec-09 | Market Sale | 21,924 | $1.43 | $31,384.20 | (3%) 721.17K to 699.25K | 93% |
| 23-Dec-09 5:29 PM View: | Pure Bioscience (PURE) | 21-Dec-09 | Market Sale | 35,243 | $1.45 | $51,134.10 | (5%) 734.49K to 699.25K | 93% |
| 31-Dec-09 4:36 PM View: | Pure Bioscience (PURE) | 15-Dec-09 | Gift | 15,340 | $1.63 | $25,004.20 | (2%) 665.39K to 650.05K | 93% |
| 16-Dec-09 4:30 PM View: | Pure Bioscience (PURE) | 14-Dec-09 | Payment of Exercise | 48,182 | $1.65 | $79,500.30 | (6%) 806.1K to 757.92K | 94% |
| 16-Dec-09 4:30 PM View: | Pure Bioscience (PURE) | 14-Dec-09 | Option Exercise | 150,000 | $0.53 | $79,500.00 | 23% 656.1K to 806.1K | |
| 22-Jul-09 6:05 PM View: | Pure Bioscience (PURE) | 21-Jul-09 | Market Purchase | 10,000 | $1.67 | $16,700.00 | 2% 646.1K to 656.1K | (94%) |
| 18-May-09 7:03 PM View: | Pure Bioscience (PURE) | 14-May-09 | Grant | 21,700 | $2.34 | $50,778.00 | 3% 624.4K to 646.1K | (96%) |
| 27-Apr-09 4:42 PM View: | Pure Bioscience (PURE) | 23-Apr-09 | Market Purchase | 5,000 | $1.69 | $8,450.00 | < 1% 619.4K to 624.4K | (94%) |
| 09-Apr-09 5:55 PM View: | Pure Bioscience (PURE) | 07-Apr-09 | Market Purchase | 5,000 | $1.75 | $8,749.50 | < 1% 614.4K to 619.4K | (94%) |
| 25-Mar-09 9:51 AM View: | Pure Bioscience (PURE) | 20-Mar-09 | Market Purchase | 5,000 | $1.75 | $8,750.00 | < 1% 609.4K to 614.4K | (94%) |
| 18-Mar-09 6:02 PM View: | Pure Bioscience (PURE) | 18-Mar-09 | Market Purchase | 5,000 | $1.82 | $9,100.00 | < 1% 604.4K to 609.4K | (95%) |
| 18-Mar-09 6:02 PM View: | Pure Bioscience (PURE) | 16-Mar-09 | Market Purchase | 5,000 | $1.94 | $9,677.00 | < 1% 604.4K to 609.4K | (95%) |
| 25-Feb-09 6:29 PM View: | Osiris Therapeutics, Inc. (OSIR) | 23-Feb-09 | Grant | 5,000 | $18.60 | $93,000.00 | 40% 12.42K to 17.42K | 5% |
| 29-Jan-09 5:12 PM View: | Pure Bioscience (PURE) | 27-Jan-09 | Option Exercise | 150,000 | $0.53 | $79,500.00 | 36% 413.4K to 563.4K | 409% |
| 29-Jan-09 5:12 PM View: | Pure Bioscience (PURE) | 27-Jan-09 | Exercise (in-the money or at-the-money) | 36,000 | $0.50 | $18,000.00 | 6% 563.4K to 599.4K | 440% |